BlackRock Amends Replimune Stake, Remains Passive Investor
Ticker: REPL · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1737953
| Field | Detail |
|---|---|
| Company | Replimune Group, Inc. (REPL) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, form-13g
TL;DR
**BlackRock still owns a chunk of Replimune, but they're just holding, not shaking things up.**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership in Replimune Group, Inc. as of December 31, 2023. This filing indicates BlackRock's continued significant, but passive, investment in Replimune's common stock. For investors, this means a major institutional investor maintains a stake, which can signal confidence, but the 'passive' nature means BlackRock isn't looking to influence company management.
Why It Matters
This filing confirms BlackRock's ongoing, substantial investment in Replimune, providing a vote of confidence from a major institutional player, though without any intent to influence company operations.
Risk Assessment
Risk Level: low — This filing is routine for large institutional investors and doesn't indicate any immediate negative or positive risk for the stock.
Analyst Insight
An investor should note that BlackRock's passive stake suggests they are not seeking to influence Replimune's management or strategy, meaning this filing doesn't signal any impending corporate action or activist pressure.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person filing the SC 13G/A
- Replimune Group, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the 'reporting person' in this filing?
The reporting person is BlackRock, Inc., identified by CIK 0001364742.
What company's securities are being reported on?
The securities of Replimune Group, Inc. (CIK 0001737953) are being reported on, specifically their Common Stock.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires filing of this statement was December 31, 2023.
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Replimune Group, Inc. (REPL).